These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 10138574)

  • 1. Quality and productivity assessment of clinical pharmacy interventions.
    Baciewicz AM; Cowan RI; Michaels PE; Kyllonen KS
    Hosp Formul; 1994 Nov; 29(11):773, 777-9. PubMed ID: 10138574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A system for documentation of pharmacist interventions with incorporation into performance and quality improvement plans.
    Brown BL; Williamson SE
    Hosp Pharm; 1993 Nov; 28(11):1083-4, 1086-8. PubMed ID: 10130385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Documenting concurrent clinical pharmacy interventions.
    Haslett TM; Kay BG; Weissfellner H
    Hosp Pharm; 1990 Apr; 25(4):351-5, 359. PubMed ID: 10104389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computerized documentation of pharmacists' interventions.
    Mason RN; Pugh CB; Boyer SB; Stiening KK
    Am J Hosp Pharm; 1994 Sep; 51(17):2131-8. PubMed ID: 7985688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, implementation, and results of a successful multidisciplinary adverse drug reaction reporting program in a university teaching hospital.
    Murphy BM; Frigo LC
    Hosp Pharm; 1993 Dec; 28(12):1199-204, 1240. PubMed ID: 10130617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of generic screening criteria for clinical interventions that link prescribing to credentialing.
    Mustion AL; Sobotka J
    Hosp Pharm; 1991 Nov; 26(11):968-72, 1015. PubMed ID: 10114824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a comprehensive clinical pharmacy workload documentation system.
    Bajcar J; Chin T; Chui W; Wichman K
    Can J Hosp Pharm; 1995 Apr; 48(2):80-9. PubMed ID: 10142842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospitals vigilant for quality in pharmacy.
    Perry PA
    Hosp Mater Manage; 1989 Dec; 14(12):1-2. PubMed ID: 10296163
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality improvement indicators for hospital/home care pharmacy.
    Rich DS
    Hosp Pharm; 1993 Oct; 28(10):992, 994-5. PubMed ID: 10129143
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the impact of a clinical pharmacist on the quality and cost of pharmacotherapy in a general surgical department, the Hillel-Yaffe Medical Center].
    Schwartzberg E; Livny S; Sterenberg A; Troitsa A; Oren M; Shani S
    Harefuah; 2003 Jan; 142(1):5-9, 80. PubMed ID: 12647481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assuring the quality of a clinical pharmacokinetics service.
    Waller DJ; Smith SR
    Am J Hosp Pharm; 1986 Sep; 43(9):2184-8. PubMed ID: 3766569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A computerized system to improve documentation and reporting of pharmacists' clinical interventions, cost savings, and workload activities.
    Zimmerman CR; Smolarek RT; Stevenson JG
    Pharmacotherapy; 1995; 15(2):220-7. PubMed ID: 7624270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The integration of quality assessment and a patient-specific intervention/outcomes program.
    Mutnick AH; Sterba KJ; Szymusiak-Mutnick BA
    Pharm Pract Manag Q; 1998 Jan; 17(4):25-36. PubMed ID: 10174746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Documentation of the first steps of pediatric pharmaceutical care in a county hospital.
    Lal LS; Anassi EO; McCants E
    Hosp Pharm; 1995 Dec; 30(12):1107-8, 1111-2. PubMed ID: 10153657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist empowerment: taking practice guidelines to the next level (Part 2).
    Puckett W; Egle L; Galt M
    Hosp Formul; 1994 Nov; 29(11):767-72. PubMed ID: 10138573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of pharmacist interventions.
    Torchinsky A; Landry D
    Can J Hosp Pharm; 1991 Oct; 44(5):245-8, 270. PubMed ID: 10115578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoeconomics and the formulary decision-making process.
    Bakst A
    Hosp Formul; 1995 Jan; 30(1):42-50. PubMed ID: 10172201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and implementation of a quality-assurance program for pharmaceutical services.
    Horowitz KN; Lamnin M
    Am J Hosp Pharm; 1980 Jan; 37(1):82-4. PubMed ID: 7361777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summary of the final report of the ASHP Quality Assurance Indicators Development Group.
    Am J Hosp Pharm; 1992 Sep; 49(9):2246-51. PubMed ID: 1524071
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuous quality assurance monitoring by staff pharmacists.
    Spradling GF
    Hosp Pharm; 1990 Nov; 25(11):1021-4, 1027. PubMed ID: 10108872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.